|
1
|
Herbst RS, Heymach JV and Lippman SM: Lung
cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
van Meerbeeck JP, Fennell DA and De
Ruysscher DK: Small-cell lung cancer. Lancet. 378:1741–1755. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Simon GR and Wagner HAmerican College of
Chest Physicians: Small cell lung cancer. Chest. 123
(Suppl):259S–271S. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jett JR, Schild SE, Kesler KA and
Kalemkerian GP: Treatment of small cell lung cancer: Diagnosis and
management of lung cancer, 3rd ed: American College of Chest
Physicians evidence-based clinical practice guidelines. Chest. 143
(5 Suppl):e400S–e419S. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu H, Zhou Z, Wang Y, et al: Thoracic
radiation therapy improves the overall survival of patients with
extensive-stage small cell lung cancer with distant metastasis.
Cancer. 117:5423–5431. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yee D, Butts C, Reiman A, et al: Clinical
trial of post-chemotherapy consolidation thoracic radiotherapy for
extensive-stage small cell lung cancer. Radiother Oncol.
102:234–238. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pignon JP, Arriagada R, Ihde DC, Johnson
DH, Perry MC, Souhami RL, et al: A meta-analysis of thoracic
radiotherapy for small-cell lung cancer. N Engl J Med.
327:1618–1624. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Warde P and Payne D: Does thoracic
irradiation improve survival and local control in limited-stage
small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol.
10:890–895. 1992.PubMed/NCBI
|
|
9
|
Takada M, Fukuoka M, Kawahara M, et al:
Phase III study of concurrent versus sequential thoracic
radiotherapy in combination with cisplatin and etoposide for
limited-stage small-cell lung cancer: Results of the Japan Clinical
Oncology Group Study 9104. J Clin Oncol. 20:3054–3060. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Simon GR and Turrisi AAmerican College of
Chest Physicians: Management of small cell lung cancer: ACCP
evidence-based clinical practice guidelines (2nd edition). Chest.
132 (3 Suppl):324–339. 2007. View Article : Google Scholar
|
|
11
|
National Comprehensive Cancer Network, .
Prostate cancer. NCCN Clinical practice guidelines in oncology. J
Natl Compr Canc Netw. 2:224–248. 2004.PubMed/NCBI
|
|
12
|
Faivre-Finn C, Lorigan P, West C and
Thatcher N: Thoracic radiation therapy for limited-stage small-cell
lung cancer: Unanswered questions. Clin Lung Cancer. 7:23–29. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Eisenhauer EA, Therasse P, Bogaerts J, et
al: New response evaluation criteria in solid tumours: Revised
RECIST guideline (version 1.1). Eur J Cancer. 45:228–247. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hoffman PC, Mauer AM and Vokes EE: Lung
cancer. Lancet. 355:479–485. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Samson DJ, Seidenfeld J, Simon GR, et al:
Evidence for management of small cell lung cancer: ACCP
evidence-based clinical practice guidelines (2nd edition). Chest.
132 (3 Suppl):314S–323S. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cooper S and Spiro SG: Small cell lung
cancer: treatment review. Respirology. 11:241–248. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kallianos A, Rapti A, Zarogoulidis P,
Tsakiridis K, Mpakas A, Katsikogiannis N, et al: Therapeutic
procedure in small cell lung cancer. J Thorac Dis. 5 (Suppl
4):S420–S424. 2013.PubMed/NCBI
|
|
19
|
Ganti AK, West WW and Zhen W: Current
concepts in the management of small cell lung cancer. Indian J Med
Res. 137:1043–1051. 2013.PubMed/NCBI
|
|
20
|
Califano R, Abidin AZ, Peck R, Faivre-Finn
C and Lorigan P: Management of small cell lung cancer: recent
developments for optimal care. Drugs. 72:471–490. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Simon M, Argiris A and Murren JR: Progress
in the therapy of small cell lung cancer. Crit Rev Oncol Hematol.
49:119–133. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
National Comprehensive Cancer Network, .
NCCN Clinical Practice Guidelines in Oncology. Small Cell Lung
Cancer. v.2:2011 https://www.nccn.org/Accessed. May
21–2011
|
|
23
|
Früh M, De Ruysscher D, Popat S, Crinò L,
Peters S and Felip EESMO Guidelines Working Group: Small-cell lung
cancer (SCLC): ESMO clinical practice guidelines for diagnosis,
treatment and follow-up. Ann Oncol. 24 (Suppl 6):vi99–vi105. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Noda K, Nishiwaki Y, Kawahara M, et al:
Irinotecan plus cisplatin compared with etoposide plus cisplatin
for extensive small-cell lung cancer. N Engl J Med. 346:85–91.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hanna N, Bunn PA Jr, Langer C, et al:
Randomized phase III trial comparing irinotecan/cisplatin with
etoposide/cisplatin in patients with previously untreated
extensive-stage disease small-cell lung cancer. J Clin Oncol.
24:2038–2043. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Natale RB, Lara PN, Chansky K, Crowley JJ,
Jett JR, Carleton JE, et al: S0124: A randomized phase III trial
comparing irinotecan/cisplatin (IP) with etoposide/cisplatin (EP)
in patients (pts) with previously untreated extensive stage small
cell lung cancer (E-SCLC). J Clin Oncol. 26 (Suppl):7512–2008
|
|
27
|
Toy E, Macbeth F, Coles B, Melville and
Eastwood A: Palliative thoracic radiotherapy for non-small-cell
lung cancer: A systematic review. Am J Clin Oncol. 26:112–120.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jeremic B, Shibamoto Y, Nikolic N, et al:
Role of radiation therapy in the combined-modality treatment of
patients with extensive disease small-cell lung cancer: A
randomized study. J Clin Oncol. 17:2092–2099. 1999.PubMed/NCBI
|
|
29
|
Turrisi AT III, Kim K, Blum R, Sause WT,
Livingston RB, Komaki R, et al: Twice-daily compared with
once-daily thoracic radiotherapy in limited small-cell lung cancer
treated concurrently with cisplatin and etoposide. N Engl J Med.
340:265–271. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Watkins JM, Fortney JA, Wahlquist AE,
Shirai K, Garrett-Mayer E, Aguero EG, et al: Once-daily
radiotherapy to > or =59.4 Gy versus twice-daily radiotherapy to
> or =45.0 Gy with concurrent chemotherapy for limited-stage
small-cell lung cancer: a comparative analysis of toxicities and
outcomes. Jpn J Radiol. 28:340–348. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Schild SE, Bonner JA, Shanahan TG, et al:
Long-term results of a phase III trial comparing once-daily
radiotherapy with twice-daily radiotherapy in limited-stage
small-cell lung cancer. Int J Radiat Oncol Biol Phys. 59:943–951.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Giuliani ME, Atallah S, Sun A, et al:
Clinical outcomes of extensive stage small cell lung carcinoma
patients treated with consolidative thoracic radiotherapy. Clin
Lung Cancer. 12:375–379. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schiller JH, Adak S, Cella D, et al:
Topotecan versus observation after cisplatin plus etoposide in
extensive-stage small-cell lung cancer: E7593 - a phase III trial
of the Eastern Cooperative Oncology Group. J Clin Oncol.
19:2114–2122. 2001.PubMed/NCBI
|
|
34
|
Slotman B, Faivre-Finn C, Kramer G, Rankin
E, Snee M, Hatton M, et al: Prophylactic cranial irradiation in
extensive small-cell lung cancer. N Engl J Med. 357:664–672. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Roeder F, Friedrich J, Timke C, Kappes J,
Huber P, Krempien R, Debus J and Bischof M: Correlation of
patient-related factors and dose-volume histogram parameters with
the onset of radiation pneumonitis in patients with small cell lung
cancer. Strahlenther Onkol. 186:149–156. 2010. View Article : Google Scholar : PubMed/NCBI
|
